Comparing Rivaroxaban vs Wegovy
Rivaroxaban | Wegovy (semaglutide) |
|
---|
Rivaroxaban | Wegovy (semaglutide) |
|
|||||||
---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Atrial Fibrillation, Cardiovascular Risk Reduction, Coronary Artery Disease, Congenital Heart Disease, Deep Vein Thrombosis, Deep Vein Thrombosis Prophylaxis after Hip Replacement... View more |
Prescription only
Prescribed for Weight Loss (Obesity/Overweight), Cardiovascular Risk Reduction. Wegovy may also be used for purposes not listed in this medication guide. |
Related suggestions Cardiovascular Risk Reduction
|
|||||||
More about Rivaroxaban | More about Wegovy (semaglutide) | ||||||||
Ratings & Reviews | |||||||||
Rivaroxaban has an average rating of 5.3 out of 10 from a total of 251 ratings on Drugs.com. 37% of reviewers reported a positive effect, while 43% reported a negative effect. |
Wegovy has an average rating of 7.6 out of 10 from a total of 511 ratings on Drugs.com. 66% of reviewers reported a positive effect, while 14% reported a negative effect. |
||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Rivaroxaban side effects |
View all Wegovy side effects |
||||||||
Drug Class | |||||||||
Generic Availability | |||||||||
Lower cost generic |
|||||||||
Pricing and Coupons * Prices are without insurance | |||||||||
View all Rivaroxaban prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
Dosage Forms | |||||||||
|
|
||||||||
Brand Names | |||||||||
Xarelto | Other semaglutide brands include: Ozempic, Rybelsus | ||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
13 hours |
168 hours |
||||||||
CSA Schedule 1 View glossary of CSA terms | |||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | |||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||
Drug Interactions | |||||||||
A total of 387 drugs are known to interact with Rivaroxaban:
|
A total of 274 drugs are known to interact with Wegovy:
|
||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|||||||||
Disease Interactions | |||||||||
First Approval Date | |||||||||
July 01, 2011 |
N/A |
||||||||
WADA Class View classifications | |||||||||
N/A |
N/A |
||||||||
More Information | |||||||||
Patient Resources | |||||||||
Professional Resources | |||||||||
Related Treatment Guide | |||||||||
|
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Xarelto
Xarelto (rivaroxaban) is a factor Xa inhibitor used to reduce the risk of blood clots and stroke in ...
Cardizem
Cardizem is used to treat hypertension (high blood pressure), angina (chest pain), and heart rhythm ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Lanoxin
Lanoxin (digoxin) is used to treat congestive heart failure and atrial fibrillation. Includes ...
Multaq
Multaq (dronedarone) is an antiarrhythmic medication used to treat atrial fibrillation and atrial ...
Edoxaban
Edoxaban is used for atrial fibrillation, deep vein thrombosis, prevention of thromboembolism in ...
Propafenone
Propafenone is used for atrial fibrillation, atrial flutter, ventricular tachycardia ...
Sotalol
Sotalol is a beta-blocker with antiarrhythmic properties that affects the heart and circulation ...
Flecainide
Flecainide is used for atrial fibrillation, atrial flutter, paroxysmal supraventricular ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.